Newtyn Management, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Theravance Biopharma, Inc. (TBPH)

Filing Manager
Newtyn Management, LLC
Reporting Manager
Newtyn Management, LLC
Security
Theravance Biopharma, Inc. Ordinary Share $0.00001 par value
Symbol
TBPH
Shares outstanding
49M shares
Disclosed Ownership
4.76M shares
Ownership
9.7%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:05 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Newtyn Management, LLC 9.7% 4.76M 4.76M 0 /s/ Eugene Dozortsev Eugene Dozortsev, Authorized Signatory
Newtyn TE Partners, LP 5.9% 2.9M 2.9M 0 /s/ Eugene Dozortsev Eugene Dozortsev, Authorized Signatory of Newtyn Management, LLC, the Investment Manager